Anaclim, LLC and Maaguzi, LLC Form a Collaboration That Will Maximize Services Available for Patient Related Health Outcome Data.
Dr. Alfonso Alanis, CEO of Anaclim, LLC said, "This is an absolutely perfect alliance in that it will result in the best service available to Bio-Pharmaceutical and Medical Device manufacturers in their desire to collect and process patient outcome information in an efficient, quick and high quality manner. We are excited and very much look forward to working with Maaguzi in offering a package of services to customers that now spans the full spectrum of the clinical trial process."
The combination of Maaguzi's OutcomeLogix technology with Anaclim's proven data management capabilities creates a unique product for customers. In addition to being patient and investigator friendly, the combined product will efficiently gather health outcome information for trials in all phases of research with accuracy, quality and speed.
Raul Zavaleta, CEO of Maaguzi, LLC adds, "This agreement originated from working together on a full data management solution involving 1,500 patients for a top 10 global pharmaceutical client. The combination of Anaclim's clinical expertise and Maaguzi's consulting and technology experience appealed to our client and reinforced our desire to formalize this compelling combined offering."
About Anaclim, LLC
Anaclim, LLC is a privately owned, full service, Contract Research Organization (CRO) that conducts clinical trials that include minority participation. Anaclim has access to a very diverse group of investigators and patients and thus is able to deliver clinical trial data in populations of patients that mirror the epidemiology of the disease being studied. Anaclim's services cover all aspects of the clinical trial execution process. Anaclim was founded by Dr. Alfonso Alanis and Mr. Rex Alexander after both enjoyed a long and successful career at Eli Lilly and Company (LLY).
Anaclim is a minority business enterprise (MBE) based in Indianapolis, Indiana.
About Maaguzi, LLC
Maaguzi is a leading provider of internet based Patient Reported Outcomes (PRO) solutions for the Life Science Industry. Through the innovative use of technology and an extensive understanding of drug development and consumer interactions, the company is improving the involvement of patients and other parties in the clinical research and post marketing areas. Maaguzi's technology has been used in therapeutic areas such as Men's Health, CNS related areas such as Depression, Anxiety, Schizophrenia, ADHD and Endocrinology. The company has recently released OutcomeLogix, the industries first product to harmonize the collection of Investigator collected data, the collection of internet based Patient Reported Outcomes and other Health Outcome reporting into a single interface and database. This requires zero integration and mapping from separate EDC and ePRO sources.
|Printer friendly Cite/link Email Feedback|
|Date:||Mar 22, 2007|
|Previous Article:||Research and Markets: Examine Recent Activity at the Bank of China With New Report.|
|Next Article:||FMT Named Cool Vendor by Gartner.|